Claudia Sala

6PUBLICATIONS
48CO-AUTHORS
NanomedicineMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Microbial ecologyEnergy generation, conversion and storage (excl. chemical and electrical)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 21, 2025
Human monoclonal antibodies targeting subdominant meningococcal antigens confer cross-protection against gonococcus.

Marco Troisi, Monica Fabbrini, Samuele Stazzoni

|May 25, 2024
Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance.

Chiara La Guidara, Roberto Adamo, Claudia Sala

|Sep 23, 2022
Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions.

Fabiola Vacca, Claudia Sala, Rino Rappuoli

|Aug 26, 2022
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections.

Pardis Mokhtary, Zeinab Pourhashem, Akram Abouei Mehrizi

|Oct 12, 2020
Multicenter analysis of sputum microbiota in tuberculosis patients.

Claudia Sala, Andrej Benjak, Delia Goletti

|Dec 21, 2018
EspL is essential for virulence and stabilizes EspE, EspF and EspH levels in Mycobacterium tuberculosis.

Claudia Sala, Nina T Odermatt, Paloma Soler-Arnedo

Pageof 1

Frequent Collaborators

2 joint publications

Pardis Mokhtary

1 joint publications

Nina T Odermatt

1 joint publications

Paloma Soler-Arnedo

1 joint publications

Sofia von Schultz